Dawud Tamer M, Dawud Abdullah T
Department of Nuclear Medicine, Cleveland Clinic Imaging Institute, Cleveland, Ohio, USA.
Independent Researcher, Ellicott City, Maryland, USA.
Case Rep Radiol. 2025 Aug 4;2025:9992200. doi: 10.1155/crra/9992200. eCollection 2025.
A 40-year-old female with estrogen receptor-positive breast cancer underwent an initial staging using a technetium-99m methylene diphosphonate (Tc-99m MDP) bone scan, which revealed abnormal uptake in the femur without a patient history of prior trauma or associated symptoms. Subsequently, an MRI confirmed the presence of a well-defined lesion in the upper left femur. To rule out metastatic disease, an 18F-fluoroestradiol (FES) PET/CT was performed, demonstrating no ER expression. Following the PET/CT, a biopsy confirmed the presence of an enchondroma. This case underscores the importance of early utilization of 18F-FES PET/CT in breast cancer staging to minimize unnecessary additional procedures/imaging.
一名40岁雌激素受体阳性乳腺癌女性患者,首次分期采用锝-99m亚甲基二膦酸盐(Tc-99m MDP)骨扫描,结果显示股骨摄取异常,患者既往无创伤史或相关症状。随后,MRI证实左股骨上段存在边界清晰的病变。为排除转移性疾病,进行了18F-氟雌二醇(FES)PET/CT检查,结果显示无雌激素受体(ER)表达。PET/CT检查后,活检证实为内生软骨瘤。该病例强调了在乳腺癌分期中早期使用18F-FES PET/CT的重要性,以尽量减少不必要的额外检查/影像学检查。